Jascayd Tablet, Film Coated
Product Images NDC 0597-2465

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Jascayd (NDC 0597-2465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Jascayd 01)

Chemical structure diagram of nerandomilast, the active ingredient in JASCAYD tablets. The structure shows molecular rings including a sulfur-oxygen group and chlorine-substituted pyrimidine, representing the chemical composition of the drug.*

FDA Label Image

Figure 1 (Jascayd 02)

A line graph displaying the mean change from baseline in FVC (mL) over a 52-week period for JASCAYD 18 mg bid versus placebo. The x-axis shows time points from baseline to 52 weeks, and the y-axis shows mean change in FVC. Two lines represent treatment groups: JASCAYD 18 mg bid (solid line with filled circles) and placebo (dashed line with open circles), with error bars indicating standard error. Patient counts for each group at each time point are listed below the x-axis.*

FDA Label Image

Figure 2 (Jascayd 03)

A Kaplan-Meier survival curve chart comparing cumulative incidence of death over time (months) between a placebo group and a JASCAYD 18 mg twice daily group. The chart includes hazard ratio data and censored data points, illustrating relative survival outcomes throughout the clinical trial period.*

FDA Label Image

Chemical Structure (Jascayd 04)

JASCAYD 18 mg film-coated tablets carton and blister card packaging by Boehringer Ingelheim Pharmaceuticals, Inc. The image shows a white and blue box with the JASCAYD name and strength prominently displayed and a blister card containing 10 film-coated tablets arranged in two rows.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Carton)

Jascayd 9 mg (nerandomilast tablets) film-coated tablets packaging label. The label indicates the product is prescription-only and contains 60 tablets. It is labeled with the manufacturer Boehringer Ingelheim Pharmaceuticals, Inc., and shows the NDC number 0597-2465-41.*

FDA Label Image

Principal Display Panel (18 mg Tablet Bottle Carton)

Packaging label for Jascayd (nerandomilast) tablets, 18 mg strength, film coated, in a package containing 60 tablets. The label shows the brand name with a colorful logo, indicates prescription use, and names Boehringer Ingelheim Pharmaceuticals, Inc. as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.